AeroRx Announces $21M Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage ...
Roger Jeffs, Chief Executive Officer of Liquidia, said: ”Our first R&D Day represents an important milestone as we bring together our team with recognized experts in the fields of PAH and PH-ILD to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback